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Selecting a Database for Drug Literature
Retrieval: A Comparison of MEDLINE,
Scopus, and Web of Science
SVETLA BAYKOUCHEVA
University of Maryland, College Park, Maryland
Three widely used databases—MEDLINE, Scopus, and Web of
Science—were compared for their relative ability to retrieve the
largest number of articles within the drug literature, using three
search terms: two for specific drugs (atorvastatin and olanzapine)
and one for a major class of drugs (statins). These drugs and the
class of drugs were chosen for their longevity and continued high
clinical and scientific interest, as indicated by the many articles
concerning them published in scholarly and professional journals
over the last two decades. Significant differences were observed in
the journal coverage and the number of documents each database
retrieved, with Scopus significantly outperforming the other two
databases in these respects. Based on the results from this lim-
ited but by no means atypical study of comparative strengths and
degree of coverage, the best option for retrieving the largest num-
bers of articles on a particular drug in the literature would be to
use both Scopus and Web of Science, as these two databases com-
plement each other with respect to the journal coverage. MEDLINE
retrieved much smaller numbers of documents in all searches
and should be used only when the other two databases are not
available.
KEYWORDS databases, information retrieval, drug literature,
MEDLINE, Scopus, Web of Science, journal coverage
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INTRODUCTION
With the enormous growth of the drug literature and the availability of sev-
eral databases for retrieving it, users sometimes find it difficult to decide
which database would serve them best. Considerations such as source
coverage, access (e.g., free vs paid, number of simultaneous users), and
functionality have been important factors in making these decisions.
For a long time the most widely used database for searching the
biomedical literature has been MEDLINE, available either through PubMed
or from platforms provided by different vendors (Bianchi 2002; Thompson
and Williams 2007; Weiner 2009). The users’ experiences and the results
from searching the same database through different platforms may vary, as
better and more sophisticated analytical and refining tools are being con-
stantly developed by vendors (Bandyopadhyay 2010). SciFinder (SF) is a
platform that carries two large databases—CAPLUS and MEDLINE, which
can be searched together or separately. This platform is used mainly by
chemists and researchers involved in drug discovery (Haldeman et al. 2005).
It is rarely used by researchers in the life sciences/biomedical field to search
the drug literature, because they are usually not aware that SF also carries
MEDLINE. Another reason SF has not gained wider acceptance for drug
research is the fact that access to it is limited to only a few simultaneous
users, depending on licensing arrangements.
Drug research is an area of science where chemistry, biology, and
medicine intersect and some authors have pointed out that MEDLINE/
PubMed alone is not always sufficient to retrieve biomedical literature
(Suarez-Almazor et al. 2000). Interdisciplinary databases such as Scopus and
Web of Science (WoS) are becoming more and more attractive to students
and researchers for searching the drug literature. Several articles have com-
pared Scopus and WoS for journal title overlap (Gavel and Iselid 2008),
content and searching capabilities (Fingerman 2006; Salisbury 2009), and
major features (Goodman and Deis 2007; Jacso 2005). Two other articles
analyzed PubMed and Google Scholar (Anders and Evans 2010; Shultz 2007),
and one article examined the strengths and weaknesses of PubMed, Scopus,
Web of Science, and Google Scholar (Falagas et al. 2008).
Scopus and WoS are expensive services and there are many institu-
tions that cannot afford subscribing to both of them. Librarians and users
are often trying to find out how Scopus and WoS compare to each other
and to MEDLINE/PubMed in covering the biomedical literature in general,
and the drug literature in particular. The interest in knowing the answers
to these questions justifies a quantitative evaluation of the performance
of MEDLINE, Scopus, and WoS in retrieving the drug literature, which is
the purpose of this study. The results reported in this article will help

































quantitative data useful in recommending the best resource to users or when
making recommendations for subscriptions.
In order to be able to compare the databases, identical keyword
searches were performed in all databases using as examples the names
of two individual drugs (atorvastatin and olanzapine) and the name of a
group of drugs (statins). Atorvastatin (also known under its brand name
Lipitor) is a cholesterol-lowering drug belonging to the group of statins
(Pfizer 2010). It has been studied extensively for a long time and is the best-
selling drug that has ever been on the market. Olanzapine (from Eli Lilly)
is a second-generation antipsychotic that was approved for the treatment
of schizophrenia, bipolar disorder, and associated agitation (Callaghan et
al. 1999). Both drugs have been on the market for more than 20 years
and have generated a significant volume of literature. The group of statins
includes cholesterol-lowering drugs that have also been studied extensively
for a long period of time (Davidson and Robinson 2006). The document
sets obtained from each database were further analyzed and compared for
total and annual output. The journal coverage was evaluated by analyzing
and comparing the lists of the top 20 journal titles from which the databases
have retrieved the highest number of documents.
METHODOLOGY
Databases
● MEDLINE (National Library of Medicine, National Institutes of Health) was
searched through SciFinder Scholar Web (SF) (Chemical Abstracts Service).
SF was chosen as a platform from which to search MEDLINE, because
it provides sophisticated analytical tools that are similar to those avail-
able from Scopus and Web of Science. Such tools are not available when
MEDLINE is used through PubMed. The initial searches performed in SF
retrieved document sets that were further refined by database to limit the
documents to those that were obtained from MEDLINE.
● Scopus (Elsevier).
● Web of Science (WoS) (ISI-Thomson Reuters).
Selection of Drugs
The names of two individual drugs, atorvastatin (Lipitor) and olanzapine,
and the name of a group of drugs, statins, were used as keywords in
test searches performed in all databases. These drugs were selected for
the following reasons: (1) Both atorvastatin and olanzapine have been on
the market for more than 20 years and have been researched extensively;
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drugs that have such different properties, effects, and history may provide
a basis for predicting the performance of the databases when retrieving lit-
erature on other drugs; and (3) using both individual drugs and a group
of drugs as models allows testing the ability of the databases to search for
literature on specific drugs or on a group of drugs.
Search Strategy
The following identical keyword searches were performed in all databases:
Strategy 1: atorvastatin OR lipitor.
Strategy 2: olanzapine.
Strategy 3: (statin OR statins) AND cholesterol.
In strategies 1 and 2 the names of the individual drugs were used
as key words. In Strategy 3 the name of the group of drugs (statin OR
statins) and the term “cholesterol” were used as keywords, to avoid retriev-
ing literature on drugs that contain the word “statin” as part of their names
but that do not belong to the group of statins. The obtained document
sets were analyzed for total and annual output. The journal coverage by
the databases was evaluated by analyzing and comparing the lists of the
top twenty journal titles from which the databases have found the highest
number of articles. All searches were performed on July 27, 2010, and all
documents retrieved from the databases by that date were included in the
study.
RESULTS
Total and Annual Literature Output
Figure 1 shows the total numbers of records on atorvastatin, olanzapine, and
statins retrieved by each database.
Atorvastatin: The results from analyzing the sets of documents on atorvas-
tatin showed that the first record on atorvastatin was published in 1990
and was retrieved by both MEDLINE and Scopus. Figure 2 shows the
yearly output of literature on atorvastatin published only from 1995 to
2010, which is the most active publication period for this drug.
Olanzapine: Figure 3 shows the annual output of literature on olanzap-
ine published from 1995 to 2010. The time period for the literature on
this drug started in 1992, with all databases retrieving two documents for
that year.
Statins: The time period for the literature on statins started in 1976, with
MEDLINE being the only database that contained records published before

































FIGURE 1 Total output of records retrieved from the databases.
FIGURE 2 Annual output of records on atorvastatin (1995–2010).
∗ (Incomplete year)
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FIGURE 4 Annual output of records on statins (1995–2010).
∗ (Incomplete year)
annual output of documents on statins retrieved by the databases for the
time period from 1995 to 2010 is shown in Figure 4.
Journal Coverage by the Databases
The journal coverage by the databases was evaluated by analyzing and com-
paring the lists of the top 20 journals from which the databases had retrieved
the highest number of documents.
Atorvastatin: As shown in Table 1, seven of the top twenty journal titles
that have published articles on atorvastatin were shared by all databases.
The number of documents each database retrieved from these shared
journals is illustrated in Figure 5. The list created by MEDLINE con-
tained one unique title and twelve titles that were shared with one of
the other databases. Scopus had six unique titles and seven titles that
were shared with one of the other databases. WoS had nine unique
titles and four journal titles that were shared with one of the other
databases.
Olanzapine: Table 2 includes the lists of the top twenty journals from which
the three databases have retrieved the highest number of documents pub-
lished on the drug olanzapine. There were fourteen journal titles on these
lists that were shared by all three databases shown in Figure 6. MEDLINE
had three unique titles and three titles that were present on the list of one
of the other databases. The list of Scopus had two unique titles and four
titles that were present also on the list of one of the other databases. The
list from WoS had three unique titles and three titles that were present
also on the list of one of the other databases.
Statins: Table 3 shows the lists of the top twenty journals from which the
databases have retrieved the highest number of documents on statins.
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FIGURE 5 Journal titles with records on atorvastatin that were shared by the top twenty
lists of all databases: A, American Heart Journal; B, American Journal of Cardiology; C,
Atherosclerosis; D, Circulation; E, Current Medical Research and Opinion; F, International
Journal of Cardiology; G, Journal of the American College of Cardiology.
had four unique titles and shared two titles with one of the other data-
bases. The list of Scopus had three unique titles and shared three titles
with one of the other databases. The list of WoS contained five unique
titles and shared one title with one of the other databases.
DISCUSSION
The comparison of the total and annual output of documents obtained
from the databases showed that Scopus performed better than the other
two databases in these respects (Figures 1–4). The differences between the
databases were less significant when the searches were performed using
as keywords the name of a group of drugs (statins) (Figure 4) rather
than the names of individual drugs (atorvastatin and olanzapine) (Figure 2
and Figure 3). Significant differences were found in the journal titles the
databases are covering and in the number of documents they retrieved from
the same journals (Tables 1–3).
A comparison of the number of documents from the seven overlapping
journals that have published articles on atorvastatin showed that Scopus and
WoS retrieved the highest number of articles from four and three journals,
respectively (Figure 5). From all overlapping journals MEDLINE retrieved
fewer documents than the other two databases. From the fourteen over-
lapping journal titles that have published articles on olanzapine (Figure 6),
Scopus retrieved the highest number of documents from nine of the shared
journals and WoS obtained the highest number of documents from five

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Databases for Drug Literature Retrieval 285
FIGURE 6 Journal titles with records on olanzapine that were shared by the top twenty lists
of all databases: A, American Journal of Psychiatry; B, Biological Psychiatry; C, CNS Drugs;
D, European Psychiatry; E, International Clinical Psychopharmacology; F, Journal of Children
and Adolescent Psychopharmacology; G, Journal of Clinical Psychopharmacology; H, Journal
of Clinical Psychiatry; I, Journal of Psychopharmacology; J, Neuropsychopharmacology;
K, Pharmacopsychiatry; L, Progress in Neuro-Psychopharmacology & Biological Psychiatry;
M, Psychopharmacology; N, Schizophrenia Research.
the highest number of documents. From the fourteen shared journals that
have published documents on statins (Figure 7), the performance of WoS,
Scopus, and MEDLINE was best with respect to eight, four, and two journals,
respectively.
This article shows that significant differences existed not only in the
journal titles but also in the number of documents that the databases
retrieved from the same journals. Scopus and WoS complemented well each
other in terms of journal coverage, which makes using both of them the best
option for comprehensive retrieval of the drug literature.
The results from this study provide information about the performance
of Scopus and WoS in a specific area (drug literature). They support the
results reported by other authors (Goodman and Deis 2007) who have con-
cluded that the two databases are complementary and that a library that can
afford it should subscribe to both of them.
CONCLUSIONS
Since the introduction of Scopus in 2004, many users and librarians have
been trying to evaluate and compare it to WoS. The much easier to navigate
interface and the possibility of viewing immediately, on the same screen,
the results from analyzing the search results make Scopus a very attractive
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FIGURE 7 Journal titles with records on statins that were shared by the top twenty lists of all
databases: A, American Heart Journal; B, American Journal of Cardiology; C, Arteriosclerosis,
Thrombosis, and Vascular Biology; D, Atherosclerosis; E, Circulation; F, Clinical Cardiology;
G, Clinical Therapy; H, Current Medical Research and Opinion; I, Current Opinion in
Lipidology; J, European Heart Journal; K, International Journal of Clinical Practice; L,
Journal of the American College of Cardiology; M, International Journal of Cardiology; N,
Lancet.
study showed, Scopus also performed much better than WoS or MEDLINE
in retrieving the drug literature.
Since the differences in the performance of the databases followed the
same patterns and were independent of the nature of the drug used in the
keyword searches, it can be expected that the databases would show similar
performance when they are searched for literature on other drugs. Based on
the results from this study, the best option for comprehensive retrieval of the
drug literature would be to use both Scopus and WoS, as these databases
complement each other well with respect to the journal coverage. If an
institution has to make a decision to choose between Scopus and WoS,
Scopus would be a better choice for this kind of literature. Since MEDLINE
has found significantly fewer documents than the other two databases, it
should be used only when these two databases are not available.
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